Virgilio, E.; Puricelli, C.; Clemente, N.; Ciampana, V.; Imperatore, Y.; Perga, S.; Stangalini, S.; Boggio, E.; Appiani, A.; Gigliotti, C.L.;
et al. The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients. Neurol. Int. 2025, 17, 110.
https://doi.org/10.3390/neurolint17070110
AMA Style
Virgilio E, Puricelli C, Clemente N, Ciampana V, Imperatore Y, Perga S, Stangalini S, Boggio E, Appiani A, Gigliotti CL,
et al. The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients. Neurology International. 2025; 17(7):110.
https://doi.org/10.3390/neurolint17070110
Chicago/Turabian Style
Virgilio, Eleonora, Chiara Puricelli, Nausicaa Clemente, Valentina Ciampana, Ylenia Imperatore, Simona Perga, Sveva Stangalini, Elena Boggio, Alice Appiani, Casimiro Luca Gigliotti,
and et al. 2025. "The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients" Neurology International 17, no. 7: 110.
https://doi.org/10.3390/neurolint17070110
APA Style
Virgilio, E., Puricelli, C., Clemente, N., Ciampana, V., Imperatore, Y., Perga, S., Stangalini, S., Boggio, E., Appiani, A., Gigliotti, C. L., Dianzani, U., Comi, C., & Vecchio, D.
(2025). The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients. Neurology International, 17(7), 110.
https://doi.org/10.3390/neurolint17070110
